Michael J. LaBarre

1.2k citations

27 papers · 820 indexed · h-index 13

Impact in

Radiology, Nuclear Medicine and Imaging top 5%
- Monoclonal and Polyclonal Antibodies Research
Immunology top 10%
- Immune Cell Function and Interaction
- Galectins and Cancer Biology

Papers in

Cell Biology 9
- Proteoglycans and glycosaminoglycans research 9
Hematology 5
- Platelet Disorders and Treatments 5

Co-authors: Mitchell E. Reff Daniel C. Maneval Liying Jiang Darrell R. Anderson Julian Davies Kenneth W. Locke Advait Badkar Shawn P. Davis
Journals: Inorganic Chemistry (2 papers)Journal of the American Chemical Society (2 papers)Biotechnology and Bioengineering (2 papers)Cancer Research (2 papers)Clinical Cancer Research (1 paper)
Partner nations: United States Israel South Korea

In The Last Decade

Michael J. LaBarre

24 papers receiving 749 citations

Peers

Countries citing papers authored by Michael J. LaBarre

Since Specialization

Citations

This map shows the geographic impact of Michael J. LaBarre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. LaBarre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. LaBarre more than expected).

Fields of papers citing papers by Michael J. LaBarre

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael J. LaBarre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. LaBarre. The network helps show where Michael J. LaBarre may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael J. LaBarre, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael J. LaBarre Line = papers co-authored together Michael J. LaBarre links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A phase I clinical study to evaluate rapid, high-volume, subcutaneous auto-injector tolerability with recombinant human hyaluronidase Drug Delivery and Translational Research ·David W. Kang, Robert Connor, Tara Nekoroski, Jo Ann M Bitsura, Susan K Kindig, Stephen P Knowles, Michael J. LaBarre	2025	0
2	The safety of recombinant human hyaluronidase PH20 in nonclinical models: An overview of toxicology, pharmacology, and impact of anti-PH20 antibodies Journal of Controlled Release ·Ryan P. Nolan, David W. Kang, Daniel C. Maneval, Stephen P Knowles, Michael J. LaBarre, Marie A. Printz	2024	1
3	Risk Factors, Hyaluronidase Expression, and Clinical Immunogenicity of Recombinant Human Hyaluronidase PH20, an Enzyme Enabling Subcutaneous Drug Administration The AAPS Journal ·Marie A. Printz, Barry J. Sugarman, Rudolph D. Paladini, Michael C. Jorge, Yan Wang, David W. Kang, Daniel C. Maneval, Michael J. LaBarre	2022	8
4	Targeting Adenosine with Adenosine Deaminase 2 to Inhibit Growth of Solid Tumors Cancer Research ·Lin Wang, Luz M. Londono, Jessica Cowell, Özge Saatci, Mertkaya Aras, Pelin G. Ersan, Sara Serra, Hong Pei, Renee Clift, Qiping Zhao, Kim B. Phan, Lei Huang, Michael J. LaBarre, Xiaoming Li, H. Michael Shepard, Silvia Deaglio, Joel Linden, Christopher D. Thanos, Özgür Şahin, Caglar Cekic	2021	29
5	Safety of recombinant human hyaluronidase PH20 for subcutaneous drug delivery Expert Opinion on Drug Delivery ·Stephen P Knowles, Marie A. Printz, David W. Kang, Michael J. LaBarre, Renee P. Tannenbaum	2021	27
6	Subcutaneous Delivery of High-Dose/Volume Biologics: Current Status and Prospect for Future Advancements Drug Design Development and Therapy ·Advait Badkar, Rajesh Gandhi, Shawn P. Davis, Michael J. LaBarre	2021	72
7	Use of computed tomography to assess subcutaneous drug dispersion with recombinant human hyaluronidase PH20 in a swine model Journal of Pharmacological and Toxicological Methods ·Robert Connor, Darin Taverna, Karla D. Thrall, Michael J. LaBarre, David W. Kang	2020	8
8	ENHANZE^® drug delivery technology: a novel approach to subcutaneous administration using recombinant human hyaluronidase PH20 Drug Delivery ·Kenneth W. Locke, Daniel C. Maneval, Michael J. LaBarre	2019	115
9	Parallel Accumulation of Tumor Hyaluronan, Collagen, and Other Drivers of Tumor Progression Clinical Cancer Research ·Xiaoming Li, H. Michael Shepard, Jessica Cowell, Chun‐Mei Zhao, Ryan J. Osgood, Sanna Rosengren, Barbara Blouw, Sheryl A. Garrovillo, Mark D. Pagel, Clifford J. Whatcott, Haiyong Han, Daniel D. Von Hoff, Darin Taverna, Michael J. LaBarre, Daniel C. Maneval, Curtis B. Thompson	2018	69
10	Kinetic investigation of recombinant human hyaluronidase PH20 on hyaluronic acid Analytical Biochemistry ·Shiping Fang, Anna-Maria A Hays Putnam, Michael J. LaBarre	2015	10
11	Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Subcutaneous (SC) Cinryze® (C1 inhibitor (C1 INH) with Recombinant Human Hyaluronidase (rHuPH20) in Subjects with Hereditary Angioedema (HAE) Journal of Allergy and Clinical Immunology ·Jennifer Schranz, Robyn J. Levy, William R. Lumry, Michael Manning, Joshua Jacobs, Samuel S. Dychter, Michael J. LaBarre, A. Phillips, Steven P Gelone, Colin Broom	2012	4
12	Development and validation of a liquid chromatography method for simultaneous determination of three process-related impurities: yeastolates, triton X-100 and methotrexate Journal of Chromatography B ·Shiping Fang, Charles P. Lollo, Celine Derunes, Michael J. LaBarre	2011	11
13	An Intermediate pH Unfolding Transition Abrogates the Ability of IgE to Interact with Its High Affinity Receptor FcϵRIα Journal of Biological Chemistry ·Stephen J. Demarest, Jennifer Hopp, Julie Chung, Karen Hathaway, Elisabeth Mertsching, Xianjun Cao, Judy George, Konrad Miatkowski, Michael J. LaBarre, Michael J. Shields, Marilyn R. Kehry	2006	14
14	Proteomic analysis of human natural killer cells: insights on new potential NK immune functions Molecular Immunology ·Jacob H. Hanna, Jonathan R. Fitchett, Tony Rowe, Mark A. Daniëls, Melissa Heller, Tsufit Gonen‐Gross, Efrat Manaster, Samuel Y. Cho, Michael J. LaBarre, Ofer Mandelboim	2004	19
15	Re-examining the oligomerization state of macrophage migration inhibitory factor (MIF) in solution Biophysical Chemistry ·John S. Philo, Tzung‐Horng Yang, Michael J. LaBarre	2004	39
16	Expression of GnTIII in a recombinant anti‐CD20 CHO production cell line: Expression of antibodies with altered glycoforms leads to an increase in ADCC through higher affinity for FCγRIII Biotechnology and Bioengineering ·Julian Davies, Liying Jiang, Li‐Zhen Pan, Michael J. LaBarre, Darrell R. Anderson, Mitchell E. Reff	2001	252
17	In vitro IgE inhibition in B cells by anti-CD23 monoclonal antibodies is functionally dependent on the immunoglobulin Fc domain International Journal of Immunopharmacology ·Takehiko Nakamura, William S. Kloetzer, Peter Brams, Kandasamy Hariharan, Soulaïma Chamat, Xianjun Cao, Michael J. LaBarre, Paul Chinn, Ron Morena, William S. Shestowsky, Yan-ping Li, Agnes Chen, Mitchell E. Reff	2000	41
18	Studies of distortional isomers. 2. Evidence that green [LWOCl2]PF6 is a ternary mixture Inorganic Chemistry ·Patrick J. Desrochers, Kenneth W. Nebesny, Michael J. LaBarre, Michael A. Bruck, G. F. Neilson, Roger P. Sperline, John H. Enemark, Gabriele Backes, Karl Wieghardt	1994	17
19	Studies of distortional isomers: spectroscopic evidence that green cis,mer-dichlorotris(dimethylphenylphosphine)oxomolybdenum(IV) is a mixture Journal of the American Chemical Society ·Patrick J. Desrochers, Kenneth W. Nebesny, Michael J. LaBarre, Sandra Lincoln, Thomas M. Loehr, John H. Enemark	1991	29
20	Phosphorus-31 NMR spectroscopy as a probe of models for the molybdenum-phosphate interaction in oxo-type molybdoenzymes and their cofactors Inorganic Chemistry ·Ulrich Kuesthardt, Michael J. LaBarre, John H. Enemark	1990	2

About Michael J. LaBarre

Michael J. LaBarre is a scholar working on Cell Biology, Hematology, Immunology, Inorganic Chemistry and Biotechnology, having authored 27 papers that have together received 820 indexed citations. Recurring topics across this work include Proteoglycans and glycosaminoglycans research (9 papers), Glycosylation and Glycoproteins Research (5 papers), Platelet Disorders and Treatments (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), T-cell and B-cell Immunology (4 papers), Peptidase Inhibition and Analysis (3 papers), Immune Cell Function and Interaction (3 papers) and Connective tissue disorders research (2 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (311 citations), Immunology (275 citations), Pharmaceutical Science (43 citations), Biotechnology (59 citations) and Immunology and Allergy (38 citations). Michael J. LaBarre has collaborated with scholars based in United States, Israel and South Korea. Frequent co-authors include Mitchell E. Reff, Daniel C. Maneval, Liying Jiang, Darrell R. Anderson, Julian Davies, Kenneth W. Locke, Advait Badkar, Shawn P. Davis, Rajesh Gandhi and John H. Enemark. Their work appears in journals such as Inorganic Chemistry, Journal of the American Chemical Society, Biotechnology and Bioengineering, Cancer Research and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact